Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

REDCLOUD BIO TO PRESENT PRECLINICAL DATA OF NEXT-GENERATION EGFR TKI H002 AT ANNUAL MEETING OF AMERICAN ASSOCIATION OF CANCER RESEARCH

SHANGHAI, April 7, 2022 /PRNewswire/ -- RedCloud Bio (the "Company"), an innovative biotech company integrating structural pharmacology and computational approaches to advance small molecule drug development, announced the upcoming presentation of preclinical data of H002, a next-generation epid...

2022-04-07 19:47 1272

REDCLOUD BIO TO PRESENT PRECLINICAL DATA OF NEXT-GENERATION EGFR TKI H002 AT ANNUAL MEETING OF AMERICAN ASSOCIATION OF CANCER RESEARCH

Contract Development and Manufacturing Organizations Shifting Focus to Meet Future Demand

An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines SAN ANTONIO, April 7, 2022 /PRNewswire/ -- Transformational forces are influencing the global contract development and manufacturing ...

2022-04-07 18:01 1491

Asset Visibility Market Opportunity in the Pharmaceutical Industry Worth US$2.7 Billion by 2026

IoT technologies contribute to rapidly expanding market for safeguarding goods as well as improving enterprises' bottom line LONDON, April 7, 2022 /PRNewswire/ -- Pharmaceutical manufacturers, distributors, and transportation providers all face unique pain points within their supply chain operat...

2022-04-07 16:00 1630

Therapy Pro wins at the 2022 Australian Disability Service Awards

* Therapy Pro has been recognised at the Australian Disability Service Awards for their innovative program offerings and positive exceptional outcomes. * Claiming "Best Early Intervention Program", the award was received by Managing DirectorPhil Laidlaw. * The Australian Disability Awards sa...

2022-04-07 12:33 1894

Rona Therapeutics Announces Completion of $33 Million Series A Financing to Advance Global Discovery and Development of RNA Therapeutics

- Funding from long-term investors to build leading delivery platform and scalable drug discovery engine to enable modular and programmable medicines - Company is harnessing the potential of RNA therapeutics to deliver medicines to liver and extrahepatic tissues with specific, stable and prolonge...

2022-04-07 12:30 2420

Psychobiotic PS128 Registration, Health Claims Approved in Thailand, Canada

TAIPEI, April 6, 2022 /PRNewswire/ -- Bened Biomedical announced recent approval of the company's probioticL. plantarum PS128 in Thailand and Canada. Authorities in each country also endorsed health claims that may be made about the strain. Local distributors will launch PS128 products this year....

2022-04-07 11:20 1221

BIO KOREA, Asia's Biggest Bio-Health Convention, to Open in May 2022

Global Event to Kick off as the Post-COVID Era Begins in Earnest, with Theme "Beyond the Pandemic, into a Next Wave" SEOUL, South Korea, April 7, 2022 /PRNewswire/ --Initiated in 2006, BIO KOREA is the biggest bio-health convention inAsia that is dedicated to promoting the international standin...

2022-04-07 10:14 2380

BIO KOREA, Asia's Biggest Bio-Health Convention, to Open in May 2022

Alterity Therapeutics Announces Presentation of bioMUSE Data at the American Academy of Neurology (AAN) Annual Meeting

* The data provides further validation of the intended Phase 2 study design MELBOURNE, Australia and SAN FRANCISCO, April 6, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treat...

2022-04-07 09:34 1685

Harbour BioMed Announces Global Out-License Agreement with AstraZeneca for CLDN18.2xCD3 Bispecific Antibody HBM7022

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, April 6, 2022 /PRNewswire/ -- Harbour BioMed ("HBM", "the Company", HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics, today announced a glob...

2022-04-07 09:09 1463

Everest Medicines Enters into an MOU for Partnership with China Resources Pharmaceutical Group for its mRNA Vaccine Business

China Resources Pharmaceutical Group ("CR Pharma") intends to make strategic equity investment for Everest's mRNA technology platform Partnership with CR Pharma will provide local support to navigate China regulatory pathways across mRNA vaccine platform, first in the advancement of Everest's po...

2022-04-07 07:30 2654

ENSEM Therapeutics, a CBC Group-Incubated Biopharma Company, Raises $67 Million in Series A Financing to Develop Small Molecule Medicines for Difficult-to-Drug Targets

BOSTON, April 6, 2022 /PRNewswire/ -- ENSEM Therapeutics Inc. (ENSEM), a Boston -based biotechnology company focusing on high value and difficult-to-drug oncology targets, announced today the closing of a series A2 financing. Incubated by CBC group since 2021, the financing is led by GGV Capital, ...

2022-04-07 04:00 1717

HitGen and UPPTHERA Extend PROTAC Research Collaboration after Hit Finding Success on Undruggable Targets

CHENGDU, China, April 6, 2022 /PRNewswire/ -- HitGen Inc. ("HitGen"), a Shanghai Stock Exchange STAR-listed company (ticker code 688222.SH), today announced that the company has successfully completed the multiple-target drug discovery research projects with UPPTHERA, a Korean pharmaceutical comp...

2022-04-06 22:30 1912

New Studies at AACR 2022 Highlight Lunit SCOPE's Immune Phenotyping Capabilities

* Lunit to present two abstracts about its AI-biomarker for immunotherapy, Lunit SCOPE IO * Lunit will deliver an oral presentation on its breakthrough study supporting the effectiveness of Lunit SCOPE IO as a prognostic biomarker for endometrial cancer SEOUL, South Korea, April 6, 2022 /PRNe...

2022-04-06 21:44 1692

New Studies at AACR 2022 Highlight Lunit SCOPE's Immune Phenotyping Capabilities

ZEISS to Unveil Clinical Insights Supporting the Value of New Data-Driven Digital Workflow Solutions and Software Applications

Advancing ophthalmic care through integrated clinical workflow solutions: * Efficiency in the cataract workflow * Can help increase treatment outcome predictability in the corneal refractive workflow * Machine learning and artificial intelligence in the retina clinic JENA, Germany and DUBLI...

2022-04-06 21:00 2004

Treadwell Therapeutics and University Health Network Sign Licensing Agreement for pre-clinical biologic and small molecule assets

NEW YORK, HONG KONG and TORONTO, April 6, 2022 /PRNewswire/ -- Treadwell Therapeutics today announced that it has entered into a license agreement with the University Health Network (UHN) inToronto, Canada for four novel oncology target programs, including a deep estate of pre-clinical therapeuti...

2022-04-06 20:59 1803

Pregene Enters into Innovative Partnership with CellPoint to Develop anti-BCMA CAR-T Cell Therapy in Europe and the US

SHENZHEN, China and LEIDEN, Netherlands, April 6, 2022 /PRNewswire/ -- Shenzhen Pregene Biopharma, a clinical-stage biopharmaceutical company engaged in discovering, developing, manufacturing and commercializes innovative medicines and CellPoint, a cell therapy company developing CAR-T therapeuti...

2022-04-06 20:30 1572

Seegene's Allplex™ RV Master Assay receives Australian TGA approval, European CE-IVD mark

* Test detects 21 targets for 19 respiratory viruses in single tube, including COVID-19 and flu * Assay result of Seegene's decades-long know-how, applies DPO∙TOCE∙MuDT technologies * "Optimal solution for safe return to normalcy as distancing restrictions eased" SEOUL, South Korea, April 6...

2022-04-06 20:08 1987

Antengene's Pivotal "MARCH" Study to Evaluate Selinexor (ATG-010) in Relapsed or Refractory Multiple Myeloma Published in BMC Medicine

- Results showed an overall response rate (ORR) of 29.3% for all treated patients. - Consistent responses across all risk groups, including patients who received prior "triple-class" and CAR-T therapies or having cytogenetic abnormalities. - Selinexor is on track for a Q2:22 launch in China. SHAN...

2022-04-06 20:03 2642

Volition appoints Sharon Ballesteros as U.S. Head of Quality and Development Process

AUSTIN, Texas, April 6, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has announced the appointment ofSharon Ballesteros as U.S Head of Quality and Development Process. Sharon has over 20 years of experience within the in vitro d...

2022-04-06 20:00 2576

Ceres Nanosciences Establishes Sixteen Wastewater-Based Epidemiology Centers of Excellence Under NIH RADx Initiative

MANASSAS, Va., April 6, 2022 /PRNewswire/ -- Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, is announcing the establishment of six new wastewater-based epidemiology centers of excellence. The new centers...

2022-04-06 19:37 2340

1 ... 259 260 261262263 264 265 ... 577